Want to see SENS full AI Analyst Report?
SENS Stock Chart & Stats
$4.86
$0.15(3.09%)
At close: 4:00 PM EDT
$4.86
$0.15(3.09%)
Day’s Range― - ―
52-Week Range$4.79 - $11.56
Previous Close$5
Volume283.30K
Average Volume (3M)741.25K
Market Cap
$513.41M
Enterprise Value$248.39
Total Cash (Recent Filing)$142.66M
Total Debt (Recent Filing)$61.84M
Price to Earnings (P/E)―
Beta1.74
Next Earnings
Nov 10, 2026EPS Estimate
-0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.27
Shares Outstanding52,874,054
10 Day Avg. Volume493,837
30 Day Avg. Volume741,251
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)3.77
Price to Sales (P/S)6.53
P/FCF Ratio-3.82
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$14.75Price Target Upside203.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)-2.4
Revenue Forecast (FY)$62.31M
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthThe higher revenue outlook and strong Q1 growth indicate expanding adoption of Eversense and improving commercial execution. Sustained patient acquisition and geographic expansion could materially increase the company’s revenue base over the next several quarters.
Improving Gross MarginGross-margin recovery from roughly breakeven in 2024 to the mid-50% range supports a stronger unit-economics profile. If maintained as volume grows, the improvement can increase gross-profit generation and create a clearer path toward operating leverage.
Patient Retention And Commercial ReachRecurring sensor replacement and improving retention can make revenue more predictable while lowering the need for constant new-patient acquisition. Eon Care’s growing insertion network also reduces access barriers, supporting broader adoption of the implantable CGM.
Bears Say
Heavy And Worsening Cash BurnThe company is not yet self-funding and cash outflows have increased materially as commercialization and development investment expands. Continued negative cash generation raises the risk that additional financing will be needed before scale produces sustainable operating cash flow.
Large Losses And Elevated Operating CostsRevenue and gross margin gains are currently outweighed by substantial selling, general and administrative and research spending. The large expense base makes profitability dependent on rapid revenue scaling, leaving execution risk high if patient growth or commercialization efficiency falls short.
Reliance On External CapitalRecent equity and debt financing provide resources for growth but also demonstrate continuing dependence on external capital. Dilution, interest obligations and the need to refinance future cash deficits could constrain shareholder value and reduce financial flexibility.
Senseonics Holdings News
SENS FAQ
What was Senseonics Holdings Inc.’s price range in the past 12 months?
Senseonics Holdings Inc. lowest stock price was $4.79 and its highest was $11.56 in the past 12 months.
What is Senseonics Holdings Inc.’s market cap?
Senseonics Holdings Inc.’s market cap is $513.41M.
When is Senseonics Holdings Inc.’s upcoming earnings report date?
Senseonics Holdings Inc.’s upcoming earnings report date is Nov 10, 2026 which is in 77 days.
How were Senseonics Holdings Inc.’s earnings last quarter?
Senseonics Holdings Inc. released its earnings results on Aug 06, 2026. The company reported -$0.63 earnings per share for the quarter, missing the consensus estimate of -$0.613 by -$0.017.
Is Senseonics Holdings Inc. overvalued?
According to Wall Street analysts Senseonics Holdings Inc.’s price is currently Undervalued.
Does Senseonics Holdings Inc. pay dividends?
Senseonics Holdings Inc. does not currently pay dividends.
What is Senseonics Holdings Inc.’s EPS estimate?
Senseonics Holdings Inc.’s EPS estimate is -0.52.
How many shares outstanding does Senseonics Holdings Inc. have?
Senseonics Holdings Inc. has 52,874,054 shares outstanding.
What happened to Senseonics Holdings Inc.’s price movement after its last earnings report?
Senseonics Holdings Inc. reported an EPS of -$0.63 in its last earnings report, missing expectations of -$0.613. Following the earnings report the stock price went up 36.311%.
Which hedge fund is a major shareholder of Senseonics Holdings Inc.?
Currently, no hedge funds are holding shares in SENS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Senseonics Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$14.75 (203.50% Upside)
$14.75 (203.50% Upside)
Blogger Sentiment
Bullish
SENS Sentiment 71%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $125.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.1%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.72%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.68%
Trailing 12-Months
Company Description
Senseonics Holdings Inc.
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
SENS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted strong commercial momentum and validating financial results: Q1 revenue of $11.7M (up 85% YoY), a 58% gross margin, rapid DTC growth (~100% YoY) and successful U.S. commercial integration. Management raised 2026 revenue guidance to $60M–$64M (70%–82% growth) and advanced pipeline milestones (Gemini and Freedom) while adding substantial growth capital ($92M equity + expanded $140M credit facility with a $20M draw). Offsetting these positives are materially higher operating expenses and an expanded net loss driven by in‑house commercialization, significant planned cash burn ($110M–$120M for 2026), increased debt, and remaining execution risk in the European transition and competitive landscape. On balance, the highlights from stronger-than-expected top-line performance, margin expansion and financing to fund growth outweigh the near-term cost and cash challenges, but execution through the rest of 2026 will be key.View all SENS earnings summariesSENS Stock 12 Month Forecast
Average Price Target
$14.75
▲(203.50% Upside)
Technical Analysis
Ownership Overview
5.73% Insiders
4.21% Mutual Funds
16.99% Other Institutional Investors
65.47% Public Companies and
Individual Investors